LSD1 promotes prostate cancer reprogramming by repressing TP53 signaling independently of its demethylase function.
Saved in:
| Title: | LSD1 promotes prostate cancer reprogramming by repressing TP53 signaling independently of its demethylase function. |
|---|---|
| Authors: | Kumaraswamy A; Department of Internal Medicine and.; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA., Duan Z; Department of Internal Medicine and.; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA., Flores D; Department of Internal Medicine and.; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA., Zhang C; Department of Internal Medicine and.; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA., Sehrawat A; Knight Cancer Institute and., Hu YM; Knight Cancer Institute and.; Biomedical Engineering Department, Oregon Health & Science University (OHSU), Portland, Oregon, USA., Swaim OA; Department of Internal Medicine and.; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA.; College of Literature, Science, and the Arts, and., Rodansky E; Department of Internal Medicine and.; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA., Storck WK; Department of Internal Medicine and.; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA., Kuleape JA; Department of Internal Medicine and.; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA., Bedi K; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA.; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA., Mannan R; Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, USA., Wang XM; Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, USA.; Michigan Center for Translational Pathology, Ann Arbor, Michigan, USA., Udager A; Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, USA., Ravikumar V; Department of Computational Medicine & Bioinformatics, University of Michigan, Ann Arbor, Michigan, USA., Bankhead A 3rd; Department of Computational Medicine & Bioinformatics, University of Michigan, Ann Arbor, Michigan, USA., Coleman I; Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Lee JK; Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Morrissey C; Department of Urology, University of Washington, Seattle, Washington, USA., Nelson PS; Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Chinnaiyan AM; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA.; Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, USA.; Michigan Center for Translational Pathology, Ann Arbor, Michigan, USA.; Department of Urology, University of Michigan Medical School, Ann Arbor, Michigan, USA.; Howard Hughes Medical Institute, Ann Arbor, Michigan, USA., Rao A; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA.; Department of Computational Medicine & Bioinformatics, University of Michigan, Ann Arbor, Michigan, USA.; Department of Radiation Oncology and.; Department of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan, USA., Xia Z; Knight Cancer Institute and.; Biomedical Engineering Department, Oregon Health & Science University (OHSU), Portland, Oregon, USA., Yates JA; Department of Internal Medicine and.; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA., Alumkal JJ; Department of Internal Medicine and.; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA.; Michigan Center for Translational Pathology, Ann Arbor, Michigan, USA. |
| Source: | JCI insight [JCI Insight] 2023 Aug 08; Vol. 8 (15). Date of Electronic Publication: 2023 Aug 08. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. |
| Journal Info: | Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model: Electronic Cited Medium: Internet ISSN: 2379-3708 (Electronic) Linking ISSN: 23793708 NLM ISO Abbreviation: JCI Insight Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
